These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27107678)

  • 21. Clinical and biological significance of transcription termination factor, RNA polymerase I in human liver hepatocellular carcinoma.
    Komatsu H; Iguchi T; Ueda M; Nambara S; Saito T; Hirata H; Sakimura S; Takano Y; Uchi R; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Eguchi H; Doki Y; Mori M; Mimori K
    Oncol Rep; 2016 Apr; 35(4):2073-80. PubMed ID: 26821084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of Graph Models to the Identification of Transcriptomic Oncometabolic Pathways in Human Hepatocellular Carcinoma.
    Barace S; Santamaría E; Infante S; Arcelus S; De La Fuente J; Goñi E; Tamayo I; Ochoa I; Sogbe M; Sangro B; Hernaez M; Avila MA; Argemi J
    Biomolecules; 2024 Jun; 14(6):. PubMed ID: 38927057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathways and gene expression profiles in hepatocellular carcinoma.
    Facciorusso A; Nacchiero MC; Rosania R; Laonigro G; Giorgio F; Del Prete V; Panella C; Ierardi E
    Minerva Gastroenterol Dietol; 2012 Mar; 58(1):35-48. PubMed ID: 22419003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of dysfunctional biological pathways and their synergistic mechanism in hepatocellular carcinoma process.
    Liang J; Lv J; Liu Z
    Exp Mol Pathol; 2015 Jun; 98(3):540-5. PubMed ID: 25805103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The HOX gene network in hepatocellular carcinoma.
    Cillo C; Schiavo G; Cantile M; Bihl MP; Sorrentino P; Carafa V; D' Armiento M; Roncalli M; Sansano S; Vecchione R; Tornillo L; Mori L; De Libero G; Zucman-Rossi J; Terracciano L
    Int J Cancer; 2011 Dec; 129(11):2577-87. PubMed ID: 21626505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression.
    Petrelli A; Perra A; Schernhuber K; Cargnelutti M; Salvi A; Migliore C; Ghiso E; Benetti A; Barlati S; Ledda-Columbano GM; Portolani N; De Petro G; Columbano A; Giordano S
    Oncogene; 2012 Oct; 31(42):4517-26. PubMed ID: 22249248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A biphasic response pattern of lipid metabolomics in the stage progression of hepatitis B virus X tumorigenesis.
    Teng CF; Hsieh WC; Yang CW; Su HM; Tsai TF; Sung WC; Huang W; Su IJ
    Mol Carcinog; 2016 Jan; 55(1):105-14. PubMed ID: 25594851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene network analysis leads to functional validation of pathways linked to cancer cell growth and survival.
    Berger E; Vega N; Vidal H; Geloën A
    Biotechnol J; 2012 Nov; 7(11):1395-404. PubMed ID: 22930530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A promoter region of the midkine gene that is frequently expressed in human hepatocellular carcinoma can activate a suicide gene as effectively as the alpha-fetoprotein promoter.
    Tomizawa M; Yu L; Wada A; Tamaoki T; Kadomatsu K; Muramatsu T; Matsubara S; Watanabe K; Ebara M; Saisho H; Sakiyama S; Tagawa M
    Br J Cancer; 2003 Sep; 89(6):1086-90. PubMed ID: 12966430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative proteomic analysis of mouse livers from embryo to adult reveals an association with progression of hepatocellular carcinoma.
    Lee NP; Leung KW; Cheung N; Lam BY; Xu MZ; Sham PC; Lau GK; Poon RT; Fan ST; Luk JM
    Proteomics; 2008 May; 8(10):2136-49. PubMed ID: 18425728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma.
    Zhang Z; Zhang Y; Sun XX; Ma X; Chen ZN
    Mol Cancer; 2015 Jan; 14():5. PubMed ID: 25608619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined functional genome survey of therapeutic targets for hepatocellular carcinoma.
    Satow R; Shitashige M; Kanai Y; Takeshita F; Ojima H; Jigami T; Honda K; Kosuge T; Ochiya T; Hirohashi S; Yamada T
    Clin Cancer Res; 2010 May; 16(9):2518-28. PubMed ID: 20388846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional and genomic implications of global gene expression profiles in cell lines from human hepatocellular cancer.
    Lee JS; Thorgeirsson SS
    Hepatology; 2002 May; 35(5):1134-43. PubMed ID: 11981763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic profiling of normal hepatocyte and hepatocellular carcinoma cells via
    Chen Y; Chen Z; Feng JH; Chen YB; Liao NS; Su Y; Zou CY
    Cell Biol Int; 2018 Apr; 42(4):425-434. PubMed ID: 29144590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma.
    Kim JK; Jung KH; Noh JH; Eun JW; Bae HJ; Xie HJ; Ahn YM; Ryu JC; Park WS; Lee JY; Nam SW
    Int J Oncol; 2009 Dec; 35(6):1257-64. PubMed ID: 19885547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.
    Chung YL; Wu ML
    J Pathol; 2013 Aug; 230(4):377-87. PubMed ID: 23620081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma.
    Zhang Y; Takahashi S; Tasaka A; Yoshima T; Ochi H; Chayama K
    J Gastroenterol Hepatol; 2013 Mar; 28(3):565-75. PubMed ID: 22989374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiomics Integration Reveals the Landscape of Prometastasis Metabolism in Hepatocellular Carcinoma.
    Li Y; Zhuang H; Zhang X; Li Y; Liu Y; Yi X; Qin G; Wei W; Chen R
    Mol Cell Proteomics; 2018 Apr; 17(4):607-618. PubMed ID: 29371291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptome and proteome of human hepatocellular carcinoma reveal shared metastatic pathways with significant genes.
    Shen H; Zhong F; Zhang Y; Yu H; Liu Y; Qin L; He F; Tang Z; Yang P
    Proteomics; 2015 Jun; 15(11):1793-800. PubMed ID: 25652264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling.
    Nam SW; Park JY; Ramasamy A; Shevade S; Islam A; Long PM; Park CK; Park SE; Kim SY; Lee SH; Park WS; Yoo NJ; Liu ET; Miller LD; Lee JY
    Hepatology; 2005 Oct; 42(4):809-18. PubMed ID: 16175600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.